The transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival

被引：0
|
作者：
Asslaber, D. [1 ]
Hofbauer, Pinon J. [1 ]
Zaborsky, N. [1 ]
Kocher, T. [1 ]
Hartmann, T. N. [1 ]
Greil, R. [1 ]
Egle, A. [1 ]
机构：
[1] Paracelsus Med Univ, Lab Immunol & Mol Canc Res, Dept Internal Med Hematol 3, Ctr Oncol, Salzburg, Austria
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [31] The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
    Seyithanoglu, Deniz
    Nazligul, Esra
    Ozbalak, Murat
    Mastanzade, Metban
    Erdem, Simge
    Nalcaci, Meliha
    Yenerel, Mustafa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S319 - S320
  • [32] A novel pro-survival and proliferation-inducing role for CCR4:TARC interaction in chronic lymphocytic leukemia (CLL) B cells
    Damle, Rajendra
    Temburni, Sonal
    Malavasi, Fabio
    Kaufman, Matthew
    Kolitz, Jonathan
    Allen, Steven
    Rai, Kanti
    Chiorazzi, Nicholas
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [33] Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia (CLL) cells from apoptosis: Role for LPA as a survival factor in CLL.
    Gibson, SB
    Hu, XJ
    Haney, N
    Kabore, AF
    Johnston, JB
    BLOOD, 2004, 104 (11) : 280B - 280B
  • [34] The effects of CDK-Multikinase inhibition in Chronic Lymphocytic Leukemia on proliferation and survival: In vitro characterization of involved pathways
    Leiser, L.
    Oelsner, M.
    Bogner, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 255 - 256
  • [35] IRF-4-Binding Protein Inhibits Interleukin-17 and Interleukin-21 Production by Controlling the Activity of IRF-4 Transcription Factor
    Chen, Qinzhong
    Yang, Wen
    Gupta, Sanjay
    Biswas, Partha
    Smith, Paula
    Bhagat, Govind
    Pernis, Alessandra B.
    IMMUNITY, 2008, 29 (06) : 899 - 911
  • [36] Chronic lymphocytic leukemia (CLL) patients at a VA medical center: Comorbidity and survival.
    Soriano, L.
    Srinivas, S.
    Tufail, M.
    Kim, K.
    Paulin, R.
    Chang, V. T.
    Kasimis, B.
    Gonzalez, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] DELAYED-HYPERSENSITIVITY RESPONSES, PALPABLE DISEASE AND SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    MOAYERI, H
    HAN, T
    SOKAL, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 239 - 239
  • [38] Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia (CLL)?
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Ilhan, Osman
    Ozcan, Muhit
    Arslan, Onder
    BLOOD, 2016, 128 (22)
  • [39] CXCR4 in Diagnosis and Prognosis of Chronic Lymphocytic Leukemia
    El-sherif, Wafaa Tohamy
    Nigm, Dalia A.
    El-din, Eman M. Salah
    Aly, Mai M.
    Said, Mohamed G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S277 - S277
  • [40] ImmunoFISH Shows That the Proliferation Centers of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Are Not Enriched for CLL-Associated Chromosomal Abnormalities
    Leeman-Neill, Rebecca J.
    Piao, Wenhua
    Sherer, Carol R.
    Cieply, Kathleen M.
    Swerdlow, Steven H.
    Gibson, Sarah E.
    MODERN PATHOLOGY, 2016, 29 : 358A - 358A
12345